Scientists from Australia and the USA have developed a lymph node-targeted multi-epitope subunit vaccine that induces strong humoral and cellular immune responses against Epstein-Barr virus (EBV) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback